Rabies Human Clinical Trial
Official title:
Randomized, Blind and Positive Control Design: a Phase III Clinical Trial to Evaluate the Consistency Between Batches of 5 Doses of Freeze-dried Rabies Vaccine (Vero Cell) and the Immunogenicity and Safety of 4 Doses of Vaccine (1-1-1-1)
To evaluate the non inferiority of the immunogenicity of the test vaccine inoculated according to the four dose immunization program over the five dose immunization program and the batches consistency of immunogenicity according to five dose immunization procedures.
- In the population aged 10-60 years, evaluate the non inferiority of the immunogenicity of the test vaccine inoculated according to the four dose immunization program (0, 3, 7, 14/28 days) over the five dose immunization program (0, 3, 7, 14, 28 days); - To evaluate the consistency of immunogenicity between batches of freeze-dried human rabies vaccine (Vero cell) inoculated according to five dose immunization procedures (0, 3, 7, 14, 28 days). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06177249 -
To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)
|
Phase 3 | |
Completed |
NCT03557008 -
Responses to Rabies Vaccine in Adults With or Without Antibiotics
|
Phase 4 | |
Completed |
NCT05549908 -
Vaccine Prevention of Rabies Adopts 4-shot Immunization Method
|
Phase 3 | |
Completed |
NCT04495569 -
A Bridging Study of the SYN023 on Healthy Adult Subjects
|
Phase 1/Phase 2 | |
Recruiting |
NCT05382650 -
Survey of Human Rabies Immune Globulin Safety in Children
|
||
Completed |
NCT04213950 -
Improving Adherence to Rabies PEP Guideline Recommendations
|
N/A |